Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fedor Simko

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 7, 2007
LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodelingLudovit Paulis, Fedor Simko
Journal of Pineal Research|July 3, 2009
Potential roles of melatonin and chronotherapy among the new trends in hypertension treatmentFedor Simko, Olga Pechanova
Clinical Science (London, England : 1979)|April 21, 2021
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?Fedor Simko, Tomas Baka
Frontiers in Cardiovascular Medicine|August 9, 2021
Monitoring Non-dipping Heart Rate by Consumer-Grade Wrist-Worn Devices: An Avenue for Cardiovascular Risk Assessment in HypertensionTomas Baka, Fedor Simko
Life Sciences|June 7, 2020
Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?Fedor Simko, Russel J Reiter
General Physiology and Biophysics|June 12, 2020
Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implicationsJaroslav Hrenak, Stefan Zorad, Fedor Simko
Current Pharmaceutical Design|September 10, 2015
N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brainJaroslav Hrenak, Ludovit Paulis, Fedor Simko
Expert Opinion on Biological Therapy|August 8, 2017
Gene therapy for hypertensionLudovit Paulis, Heinrich Franke, Fedor Simko
International Journal of Molecular Sciences|October 10, 2014
Peripheral and central effects of melatonin on blood pressure regulationOlga Pechanova, Ludovit Paulis, Fedor Simko
Current Hypertension Reports|April 21, 2015
New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?Ludovit Paulis, Romana Rajkovicova, Fedor Simko
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Hypertension (Dallas, Tex. : 1979)|November 7, 2007
LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodelingLudovit Paulis, Fedor Simko
Journal of Pineal Research|July 3, 2009
Potential roles of melatonin and chronotherapy among the new trends in hypertension treatmentFedor Simko, Olga Pechanova
Clinical Science (London, England : 1979)|April 21, 2021
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?Fedor Simko, Tomas Baka
Frontiers in Cardiovascular Medicine|August 9, 2021
Monitoring Non-dipping Heart Rate by Consumer-Grade Wrist-Worn Devices: An Avenue for Cardiovascular Risk Assessment in HypertensionTomas Baka, Fedor Simko
Life Sciences|June 7, 2020
Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?Fedor Simko, Russel J Reiter
General Physiology and Biophysics|June 12, 2020
Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implicationsJaroslav Hrenak, Stefan Zorad, Fedor Simko
Current Pharmaceutical Design|September 10, 2015
N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brainJaroslav Hrenak, Ludovit Paulis, Fedor Simko
Expert Opinion on Biological Therapy|August 8, 2017
Gene therapy for hypertensionLudovit Paulis, Heinrich Franke, Fedor Simko
International Journal of Molecular Sciences|October 10, 2014
Peripheral and central effects of melatonin on blood pressure regulationOlga Pechanova, Ludovit Paulis, Fedor Simko
Current Hypertension Reports|April 21, 2015
New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?Ludovit Paulis, Romana Rajkovicova, Fedor Simko
Pageof 9